http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0
.trig | .trig.txt | .jelly | .jelly.txt
@prefix this: <http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0> . @prefix sub: <http://purl.org/np/RAhN3pQJksh_0KrbKdsLTq8cuK0dnZRmdjPDlJhr9oxl0#> . @prefix schema: <https://schema.org/> . @prefix np: <http://www.nanopub.org/nschema#> . @prefix dct: <http://purl.org/dc/terms/> . @prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> . @prefix nt: <https://w3id.org/np/o/ntemplate/> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix orcid: <https://orcid.org/> . @prefix bl: <https://w3id.org/biolink/vocab/> . @prefix prov: <http://www.w3.org/ns/prov#> . @prefix npx: <http://purl.org/nanopub/x/> . sub:Head { this: a np:Nanopublication; np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo . } sub:assertion { <http://purl.obolibrary.org/obo/DOID_8469> bl:category bl:Disease . sub:association a rdf:Statement; rdf:object <http://purl.obolibrary.org/obo/DOID_8469>; rdf:predicate bl:treats; rdf:subject <https://identifiers.org/drugbank:DB00558>; rdfs:label "relenza an influenza virus neuraminidase inhibitor nai is indicated for treatment of acute uncomplicated influenza type a and b infections 1 1 prophylaxis of influenza 1 2 important limitations of use not recommended for treatment or prophylaxis of influenza in 5 1 not proven effective for 1 3 1 3 not a substitute for annual influenza vaccination 1 3 consider available information on influenza drug susceptibility patterns and treatment effects when deciding whether to use relenza 1 3 relenza zanamivir inhalation powder is indicated for treatment of uncomplicated acute illness due to influenza a and b virus in adults and pediatric patients aged 7 years and older who have been symptomatic for no more than 2 days relenza is indicated for prophylaxis of influenza in adults and pediatric patients aged 5 years and older see warnings and precautions 5 1"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by <https://w3id.org/um/NeuroDKG>; bl:relation schema:TreatmentIndication . <https://identifiers.org/drugbank:DB00558> bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "D8JBLUi/KjWeRBuIhOSHbhHP0zPDwmbvDFmkkpI1VByhDSYuDzixpk7qGFqntr/GaboGlDAexBWZYnnUUWwuAUTrmVuXP4cJlP311DyPjLLQAeCiXEqbyPLhPns4xstJjmjTph9MlvYUtPlw2a1ksmjfyRomwdTVJq+QTrgmOZc="; npx:hasSignatureTarget this: . this: dct:created "2021-06-15T18:36:10.185+02:00"^^xsd:dateTime; dct:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate <http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM>; nt:wasCreatedFromPubinfoTemplate <http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM>; nt:wasCreatedFromTemplate <http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs> . }